International Conference on Cytopathology and Dermatology

  24 Dec 2024 - 25 Dec 2024

   Austin, USA

conference-img

International Conference on Cytopathology and Dermatology

24 Dec 2024

 - 

25 Dec 2024

Austin, USA



The upcoming (ICCAD-24) at Austin, USA has been organized on 24th - 25th December 2024 and is scheduled to alleviate this exact challenge by serving as a focal point for researchers in the discipline of Cytopathology and Dermatology from the world over to gather together, learn from one another, impart and propagate their expertise, and put in place policies and mechanisms that will safeguard the steadfast growth and advancement of Cytopathology and Dermatology.

The (ICCAD-24) aims to be this all-so-necessary rocket fuel of progress for the field of Cytopathology and Dermatology by providing everyone from students and educators to researchers, entrepreneurs, and industry professionals, the inspiration, intellectual stimulation, and radical ingenuity that they need to be able to go out there and achieve big things.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


ASCO Annual Meeting 2026

On: 29 May 2026

-

02 Jun 2026


International Conference on Medical and Health Sciences

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Diabetes Endocrinology and Obesity

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Virology and Immunology

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


ASCO Annual Meeting 2026

On: 29 May 2026

-

02 Jun 2026


International Conference on Medical and Health Sciences

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Diabetes Endocrinology and Obesity

On: 01 Jun 2026

-

01 Jun 2026


International Conference on Virology and Immunology

On: 01 Jun 2026

-

01 Jun 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot